HealthQuill Pharma
Amgen Inc., a US biotechnology company, will set up a second drug manufacturing facility in North Carolina for $1 billion, according to a company statement.
Drugs Medical Pharma

Amgen Inc., to invest $1 billion to build a second plant in North Carolina

Amgen Inc., a US biotechnology company, will set up a second drug manufacturing facility in North Carolina for $1 billion, according to a.

Read More
Abnormal prenatal blood results are indicative of hidden cancers in pregnant women, researchers at the US nation’s medical research agency, the National Institutes of Health, found.
Health Medical Pharma Research

Prenatal blood tests may reveal hidden cancers in pregnant women: NIH

Abnormal prenatal blood results are indicative of hidden cancers in pregnant women, researchers at the US nation’s medical research agency, the National Institutes.

Read More
Health Pharma

United Healthcare’s insurance unit CEO shot dead in New York

HQ Team December 4, 2024: The CEO of United Health’s insurance arm, UnitedHealthcare, Brian Thompson, was shot dead Wednesday morning outside the Hilton.

Read More
Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine for their discoveries that led to the development of vaccines to fight the Covid-19 virus.
Health Pharma

Levothyroxine for hypothyroidism linked to bone loss in older adults

Bharti Jayshankar December 3, 2024: A study conducted by researchers at Johns Hopkins University revealed concerning links between levothyroxine—a commonly prescribed medication for.

Read More
Novartis AG, the world's fourth-largest pharmaceutical company by revenue, announced its Kisqali drug reduced breast cancer recurrence when diagnosed at an early stage and has stopped its ongoing trial.
Health Pharma

New study finds some healthy breast cells may harbor cancer cells

Bharti Jayshankar November 30, 2024: A study done by the  University of Texas MD Anderson Cancer Center revealed that some breast cells in healthy.

Read More
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Drugs Health Pharma

Roche to acquire US-based Poseida Therapeutics for $1.5 billion

Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.

Read More
Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.
Drugs Health Pharma

Cassava’s disputed Alzheimer’s drug flops in end-stage trials

Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.

Read More
Negotiators at a global climate conference signed a $300 billion-a-year deal to finance emissions reduction — that developing nations say falls way short of their expectations.
Climate Health Pharma

Global warming on backburner; vexed financing deal sees light at COP29 

Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way.

Read More
A sedentary lifestyle of more than 10.6 hours a day increases heart disease by up to 60%, according to a study by Mass General Brigham researchers.
Health Medical Pharma

Sitting for 10.6 hours a day increases heart disease risk by 60%

A sedentary lifestyle of more than 10.6 hours a day increases heart disease by up to 60%, according to a study by Mass.

Read More
The WHO says close to 18 million people die due to cardiovascular disease every year out of which maximum deaths are due to SCA. Heart attacks occur when there is a blockage in one or more of the arteries to the heart, preventing the heart from receiving enough oxygen-rich blood.
Pharma

Eli Lilly’s pill for genetic high cholesterol cuts risk by 86% in trial 2

HQ Team November 19, 2024: Eli Lilly announced promising results from its Phase 2 clinical trial of muvalaplin, an oral medication designed to.

Read More